Medly

Medly

Growth Stage

A Better Pharmacy For Everyone

A Better Pharmacy For Everyone

Overview

Funding data not publicly available
Platform

OurCrowd

Start Date

08/04/2021

Close Date

08/13/2021

Min. Goal
$10,000
Max. Goal
$1,400,000
Min. Investment

$10,000

Security Type

Equity - Common

SEC Filing Type

RegD 506(c)

Pre-Money Valuation

$700,000,000

Year Founded

2017

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Location

Brooklyn, New York

Medly, with a valuation of $700 million, is raising funds on OurCrowd through Reg D 506(c) raise. The company has developed a platform that functions as a digital pharmacy. The platform provides patient-first services and solutions that are personalized, convenient, and affordable. The pharmacy services of Medly include free and same-day delivery, co-pay management, refill management, pharmacy support, and financial support. Marg Patel, Sahaj Patel, and Chirag Kulkarni founded Medly in 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,400,000. The campaign proceeds will be used for growth and expansion.
Create a free account today to gain access to KingsCrowd analytics.

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Medly on OurCrowd 2021
Platform: OurCrowd
Security Type: Equity - Common
Valuation: $700,000,000

Follow company

Follow Medly on OurCrowd 2021

Buy Medly's Deal Report

Warning: according to the close date for this deal, Medly may no longer be accepting investments.

Medly Deal Report

Get KingsCrowd’s comprehensive report on Medly including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Medly is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Medly deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge